1. Home
  2. FOLD vs MAIN Comparison

FOLD vs MAIN Comparison

Compare FOLD & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.36

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Logo Main Street Capital Corporation

MAIN

Main Street Capital Corporation

HOLD

Current Price

$57.73

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
MAIN
Founded
2002
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
5.3B
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
FOLD
MAIN
Price
$14.36
$57.73
Analyst Decision
Buy
Hold
Analyst Count
9
7
Target Price
$27.25
$61.57
AVG Volume (30 Days)
4.2M
645.1K
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
7.50%
EPS Growth
50.00
N/A
EPS
N/A
3.95
Revenue
N/A
N/A
Revenue This Year
$20.55
$5.81
Revenue Next Year
$18.34
$2.18
P/E Ratio
N/A
$14.55
Revenue Growth
N/A
N/A
52 Week Low
$5.66
$47.00
52 Week High
$14.38
$67.77

Technical Indicators

Market Signals
Indicator
FOLD
MAIN
Relative Strength Index (RSI) 73.35 40.65
Support Level $14.21 $55.70
Resistance Level $14.37 $58.72
Average True Range (ATR) 0.04 1.82
MACD -0.04 -0.25
Stochastic Oscillator 93.75 36.99

Price Performance

Historical Comparison
FOLD
MAIN

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About MAIN Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.

Share on Social Networks: